Pro Medicus Ltd
OTC:PMCUF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pro Medicus Ltd
OTC:PMCUF
|
AU |
|
P
|
Public Storage
SWB:PUP
|
US |
|
Vaudoise Assurances Holding SA
SIX:VAHN
|
CH |
|
B
|
Berentzen Gruppe AG
LSE:0RBL
|
DE |
|
E
|
Endeavour Silver Corp
XBER:EJD
|
CA |
|
Avalo Therapeutics Inc
F:C6K0
|
US |
|
N
|
NTT Data Corp
F:NT5
|
JP |
|
Williams Companies Inc
NYSE:WMB
|
US |
|
H
|
Hawaiian Electric Industries Inc
F:HWI
|
US |
|
Mizuho Financial Group Inc
TSE:8411
|
JP |
|
LATAM Airlines Group SA
NYSE:LTM
|
CL |
|
B
|
Barclays PLC
F:BCY2
|
UK |
Wall St Price Targets
PMCUF Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for PMCUF is 149.62 USD with a low forecast of 105.98 USD and a high forecast of 187.65 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PMCUF's stock price target?
Price Target
149.62
USD
According to Wall Street analysts, the average 1-year price target for PMCUF is 149.62 USD with a low forecast of 105.98 USD and a high forecast of 187.65 USD.
What is the Revenue forecast for Pro Medicus Ltd?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Revenue has been 26%. The projected CAGR for the next 8 years is 15%.
What is the Operating Income forecast for Pro Medicus Ltd?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 67%. The projected CAGR for the next 8 years is 12%.
What is the Net Income forecast for Pro Medicus Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been 38%. The projected CAGR for the next 8 years is 13%.
